Roth Mkm Raises Helius Medical Technologies (NASDAQ:HSDT) Price Target to $24.00

Helius Medical Technologies (NASDAQ:HSDT – Free Report) had its price target hoisted by Roth Mkm to $24.00 in a research report released on Tuesday, Benzinga reports. Roth Mkm currently has a buy rating on the stock. Helius Medical Technologies Trading Up 0.7 % HSDT stock opened at $6.04 on Tuesday. The company’s 50 day moving […]

Related Keywords

Roth Mkm , Dane Andreeff , Helius Medical Technologies Company Profile , Helius Medical Technologies Inc , Blackrock Inc , Securities Exchange Commission , Vanguard Group Inc , Renaissance Technologies , Helius Medical Technologies , Free Report , Medical Technologies , Exchange Commission , Vanguard Group , Get Free Report , Portable Neuromodulation Stimulator , Helius Medical Technologies Daily ,